Page last updated: 2024-08-25

clarithromycin and Crohn Disease

clarithromycin has been researched along with Crohn Disease in 25 studies

Research

Studies (25)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (8.00)	18.2507
2000's	18 (72.00)	29.6817
2010's	4 (16.00)	24.3611
2020's	1 (4.00)	2.80

Authors

Authors	Studies
Campbell, BJ; Edwards, SW; Hart, CA; Martin, HM; Rhodes, JM; Roberts, CL; Subramanian, S	1
Begbey, A; Guppy, JH; Mohan, C; Webster, S	1
Bertani, L; Blandizzi, C; Bodini, G; Buda, A; Ceccarelli, L; Costa, F; De Bortoli, N; Facchin, S; Lorenzon, G; Marabotto, E; Marchi, S; Savarino, E; Savarino, V; Zingone, F	1
Kale-Pradhan, PB; Palmer, JR; Wilhelm, SM; Zhao, JJ	1
Belz, D; Fabri, M; Rasokat, H; Schlaak, M; Tantcheva-Poor, I	1
Chande, N; MacDonald, JK; Parker, CE; Patton, PH	1
Awotesu, O; Lightman, S; Lynn, WA; Missotten, T; Pitcher, MC	1
Bilkey, S; Borody, TJ; Leis, S; Pang, G; Tye, S; Wettstein, AR	1
Connell, W; Crotty, B; Ee, H; Florin, T; Gibson, P; Hetzel, D; Merrett, M; Mitchell, B; Pavli, P; Radford-Smith, G; Read, R; Selby, W	1
Colombel, JF; Neut, C; Peyrin-Biroulet, L	1
Chiba, T; Inoue, S; Kasahara, K; Kitamura, H; Matsuura, M; Mikami, S; Nakase, H; Tamaki, H; Ueno, S; Uza, N	1
Kuenstner, JT	1
Barash, DP; Lipton, JE	1
Biesecker, J; Gitlin, L	1
Chamberlin, W	1
Ellis, A; Leiper, K; Martin, K; Morris, AI; Rhodes, JM; Watson, AJ	1
Behr, MA; Hanley, J	1
Gui, GP; Hermon-Taylor, J; Lake, J; Sanderson, JD; Thomas, PR; Tizard, ML	1
Leiper, K; Morris, AI; Rhodes, JM	1
Hermon-Taylor, J	2
Akram, S; Goodgame, RW; Graham, D; Ike, E; Kimball, K; Ou, CN; Sutton, F	1
Borody, TJ; Leis, S; Surace, R; Warren, EF	1
El-Zaatari, FA; Kugler, L; Naser, SA; Sandoval, J; Shafran, I	1
Goh, KS; Labrousse, V; Rastogi, N	1

Reviews

4 review(s) available for clarithromycin and Crohn Disease

Article	Year
Antimicrobial treatment with the fixed-dose antibiotic combination RHB-104 for Mycobacterium avium subspecies paratuberculosis in Crohn's disease: pharmacological and clinical implications. Expert opinion on biological therapy, 2019, Volume: 19, Issue:2 Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Clofazimine; Crohn Disease; Drug Combinations; Humans; Mycobacterium avium subsp. paratuberculosis; Paratuberculosis; Remission Induction; Rifabutin	2019
The role of antimicrobials in Crohn's disease. Expert review of gastroenterology & hepatology, 2013, Volume: 7, Issue:3 Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Clarithromycin; Crohn Disease; Humans; Metronidazole; Remission Induction; Rifamycins; Rifaximin; Secondary Prevention; Treatment Outcome	2013
Anti-tuberculous therapy for maintenance of remission in Crohn's disease. The Cochrane database of systematic reviews, 2016, Jul-22, Volume: 7 Topics: Antitubercular Agents; Clarithromycin; Clofazimine; Crohn Disease; Ethambutol; Glucocorticoids; Humans; Maintenance Chemotherapy; Methylprednisolone; Prednisone; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Rifabutin; Rifampin; Secondary Prevention	2016
Antimycobacterial therapy in Crohn's disease: game over? Gastroenterology, 2007, Volume: 132, Issue:7 Topics: Anti-Bacterial Agents; Clarithromycin; Clofazimine; Crohn Disease; Drug Therapy, Combination; Humans; Mycobacterium avium; Mycobacterium Infections; Rifabutin	2007

Trials

7 trial(s) available for clarithromycin and Crohn Disease

Article	Year
Anti-mycobacterial therapy in Crohn's disease heals mucosa with longitudinal scars. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2007, Volume: 39, Issue:5 Topics: Adolescent; Adult; Anti-Infective Agents; Clarithromycin; Clofazimine; Crohn Disease; Female; Humans; Intestinal Mucosa; Male; Middle Aged; Mycobacterium avium; Retrospective Studies; Rifabutin; Treatment Outcome	2007
Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease. Gastroenterology, 2007, Volume: 132, Issue:7 Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Clofazimine; Crohn Disease; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Male; Middle Aged; Mycobacterium avium; Mycobacterium Infections; Patient Compliance; Prednisolone; Rifabutin; Treatment Failure	2007
Open label trial of clarithromycin therapy in Japanese patients with Crohn's disease. Journal of gastroenterology and hepatology, 2007, Volume: 22, Issue:7 Topics: Adult; Clarithromycin; Crohn Disease; Female; Humans; Japan; Male; Middle Aged; Protein Synthesis Inhibitors	2007
Clinical trial: randomized study of clarithromycin versus placebo in active Crohn's disease. Alimentary pharmacology & therapeutics, 2008, Volume: 27, Issue:12 Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Crohn Disease; Drug Administration Schedule; Female; Humans; Male; Placebos; Treatment Outcome	2008
Open label trial of oral clarithromycin in active Crohn's disease. Alimentary pharmacology & therapeutics, 2000, Volume: 14, Issue:6 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Crohn Disease; Female; Humans; Male; Middle Aged; Patient Compliance; Recurrence; Severity of Illness Index; Treatment Outcome	2000
Randomized controlled trial of clarithromycin and ethambutol in the treatment of Crohn's disease. Alimentary pharmacology & therapeutics, 2001, Volume: 15, Issue:12 Topics: Adult; Anti-Bacterial Agents; Antitubercular Agents; Clarithromycin; Crohn Disease; Ethambutol; Female; Follow-Up Studies; Humans; Male; Middle Aged; Treatment Outcome	2001
Open clinical trial of rifabutin and clarithromycin therapy in Crohn's disease. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2002, Volume: 34, Issue:1 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antibiotics, Antitubercular; Clarithromycin; Colonoscopy; Crohn Disease; Female; Humans; Male; Middle Aged; Mycobacterium avium subsp. paratuberculosis; Paratuberculosis; Remission Induction; Rifabutin; Treatment Outcome	2002

Other Studies

14 other study(ies) available for clarithromycin and Crohn Disease

Article	Year
Replication of Colonic Crohn's Disease Mucosal Escherichia coli Isolates within Macrophages and Their Susceptibility to Antibiotics. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:2 Topics: Animals; Anti-Bacterial Agents; Cell Line; Cells, Cultured; Colon; Crohn Disease; Culture Media; Escherichia coli; Humans; Macrophages; Mice; Microbial Sensitivity Tests; Monocytes; Mucous Membrane	2008
BMJ case reports, 2020, Dec-31, Volume: 13, Issue:12 Topics: Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Comorbidity; Crohn Disease; Enterobacteriaceae Infections; Female; Hafnia alvei; Humans; Immunocompromised Host; Male; Pneumonia, Bacterial; Pulmonary Disease, Chronic Obstructive; Rare Diseases; Treatment Outcome; Young Adult	2020
Mycobacterium marinum infection initially diagnosed as metastatic Crohn's disease. Journal of the European Academy of Dermatology and Venereology : JEADV, 2016, Volume: 30, Issue:3 Topics: Anti-Bacterial Agents; Clarithromycin; Crohn Disease; Diagnosis, Differential; Diagnostic Errors; Female; Humans; Mycobacterium Infections, Nontuberculous; Nose; Young Adult	2016
Uveitis in a patient receiving rifabutin for Crohn's disease. Journal of the Royal Society of Medicine, 2004, Volume: 97, Issue:9 Topics: Adult; Anti-Bacterial Agents; Antibiotics, Antitubercular; Clarithromycin; Crohn Disease; Drug Therapy, Combination; Female; Humans; Mycobacterium avium subsp. paratuberculosis; Paratuberculosis; Rifabutin; Tuberculosis, Ocular; Uveitis, Anterior	2004
The Australian antibiotic trial in Crohn's disease: alternative conclusions from the same study. Gastroenterology, 2007, Volume: 133, Issue:5 Topics: Anti-Bacterial Agents; Clarithromycin; Clofazimine; Crohn Disease; Drug Therapy, Combination; Humans; Mycobacterium avium subsp. paratuberculosis; Paratuberculosis; Randomized Controlled Trials as Topic; Reproducibility of Results; Research Design; Rifabutin	2007
Flawed Australian CD study does not end MAP controversy. Gastroenterology, 2007, Volume: 133, Issue:5 Topics: Anti-Bacterial Agents; Clarithromycin; Clofazimine; Crohn Disease; Drug Therapy, Combination; Humans; Mycobacterium avium subsp. paratuberculosis; Paratuberculosis; Randomized Controlled Trials as Topic; Rifabutin	2007
Australian Crohn's antibiotic study opens new horizons. Gastroenterology, 2007, Volume: 133, Issue:5 Topics: Anti-Bacterial Agents; Antibodies, Monoclonal; Clarithromycin; Clofazimine; Crohn Disease; Drug Therapy, Combination; Gastrointestinal Agents; Humans; Infliximab; Mycobacterium avium subsp. paratuberculosis; Paratuberculosis; Randomized Controlled Trials as Topic; Remission Induction; Reproducibility of Results; Rifabutin; Treatment Outcome	2007
Importance of the Australian Crohn's disease antibiotic study. Gastroenterology, 2007, Volume: 133, Issue:5 Topics: Anti-Bacterial Agents; Clarithromycin; Clofazimine; Crohn Disease; Data Interpretation, Statistical; Drug Therapy, Combination; Humans; Mycobacterium avium subsp. paratuberculosis; Paratuberculosis; Randomized Controlled Trials as Topic; Rifabutin; Treatment Outcome	2007
Antimycobacterial therapy for Crohn's disease: a reanalysis. The Lancet. Infectious diseases, 2008, Volume: 8, Issue:6 Topics: Adrenal Cortex Hormones; Antitubercular Agents; Clarithromycin; Clinical Trials as Topic; Clofazimine; Crohn Disease; Humans; Rifabutin	2008
Two-year-outcomes analysis of Crohn's disease treated with rifabutin and macrolide antibiotics. The Journal of antimicrobial chemotherapy, 1997, Volume: 39, Issue:3 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Blood Sedimentation; C-Reactive Protein; Clarithromycin; Crohn Disease; Female; Follow-Up Studies; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Proportional Hazards Models; Remission Induction; Rifabutin; Serum Albumin	1997
Protagonist. Mycobacterium avium subspecies paratuberculosis is a cause of Crohn's disease. Gut, 2001, Volume: 49, Issue:6 Topics: Animals; Animals, Domestic; Cattle; Clarithromycin; Clofazimine; Crohn Disease; Disease Reservoirs; Drug Therapy, Combination; Humans; Intestines; Milk; Mycobacterium avium subsp. paratuberculosis; Rifabutin; Sheep	2001
Treatment of severe Crohn's disease using antimycobacterial triple therapy--approaching a cure? Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2002, Volume: 34, Issue:1 Topics: Adolescent; Adult; Clarithromycin; Clofazimine; Colonoscopy; Crohn Disease; Drug Therapy, Combination; Female; Humans; Male; Mycobacterium avium subsp. paratuberculosis; Mycobacterium Infections; Pilot Projects; Prospective Studies; Rifabutin; Severity of Illness Index; Treatment Outcome	2002
Treatment with drugs active against Mycobacterium avium subspecies paratuberculosis can heal Crohn's disease: more evidence for a neglected public health tragedy. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2002, Volume: 34, Issue:1 Topics: Clarithromycin; Clofazimine; Crohn Disease; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Mycobacterium avium subsp. paratuberculosis; Paratuberculosis; Rifabutin; Vaccines, DNA	2002
Activity of clarithromycin compared with those of other drugs against Mycobacterium paratuberculosis and further enhancement of its extracellular and intracellular activities by ethambutol. Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:12 Topics: Animals; Clarithromycin; Crohn Disease; Drug Synergism; Ethambutol; Humans; Macrophages; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mycobacterium avium subsp. paratuberculosis; Oxazoles	1992